CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 3 Months Ended |
Mar. 31, 2020 | Mar. 31, 2019 |
Operating activities: | | |
Net income | $ 59,781 | $ 62,900 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation and amortization | 83,017 | 85,395 |
(Accretion) amortization of debt premium and discount, net | (79) | 468 |
Deferred financing cost amortization | 1,763 | 1,787 |
Accretion of above- and below-market leases, net | (4,229) | (4,898) |
Tenant inducement amortization and other | 897 | 827 |
Impairment of real estate assets | 4,598 | 3,112 |
Gain on sale of real estate assets | (8,905) | (7,602) |
Equity based compensation | 2,652 | 2,641 |
(Gain) loss on extinguishment of debt, net | 5 | (30) |
Changes in operating assets and liabilities: | | |
Receivables, net | (1,407) | (816) |
Deferred charges and prepaid expenses | (6,995) | (6,829) |
Other assets | (200) | 82 |
Accounts payable, accrued expenses and other liabilities | (35,828) | (40,199) |
Net cash provided by operating activities | 95,070 | 96,838 |
Investing activities: | | |
Improvements to and investments in real estate assets | (86,696) | (77,725) |
Acquisitions of real estate assets | (2,020) | 0 |
Proceeds from sales of real estate assets | 41,411 | 45,160 |
Purchase of marketable securities | (3,328) | (5,246) |
Proceeds from sale of marketable securities | 4,019 | 5,977 |
Net cash used in investing activities | (46,614) | (31,834) |
Financing activities: | | |
Repayment of secured debt obligations | (7,000) | 0 |
Repayment of borrowings under unsecured revolving credit facility | (7,500) | (65,000) |
Proceeds from borrowings under unsecured revolving credit facility | 646,000 | 50,000 |
Deferred financing and debt extinguishment costs | (404) | (133) |
Distributions to common stockholders | (85,572) | (84,097) |
Repurchases of common shares | (25,007) | (11,586) |
Repurchases of common shares in conjunction with equity award plans | (3,405) | (1,547) |
Net cash provided by (used in) financing activities | 517,112 | (112,363) |
Net change in cash, cash equivalents and restricted cash | 565,568 | (47,359) |
Cash, cash equivalents and restricted cash at beginning of period | 21,523 | 50,765 |
Cash, cash equivalents and restricted cash at end of period | 587,091 | 3,406 |
Reconciliation to consolidated balance sheets: | | |
Cash and cash equivalents | 584,830 | 349 |
Cash, cash equivalents and restricted cash at end of period | 587,091 | 3,406 |
Supplemental disclosure of cash flow information: | | |
Cash paid for interest, net of amount capitalized of $1,063 and $626 | 47,023 | 51,168 |
Brixmor Operating Partnership LP | | |
Operating activities: | | |
Net income | 59,781 | 62,900 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation and amortization | 83,017 | 85,395 |
(Accretion) amortization of debt premium and discount, net | (79) | 468 |
Deferred financing cost amortization | 1,763 | 1,787 |
Accretion of above- and below-market leases, net | (4,229) | (4,898) |
Tenant inducement amortization and other | 897 | 827 |
Impairment of real estate assets | 4,598 | 3,112 |
Gain on sale of real estate assets | (8,905) | (7,602) |
Equity based compensation | 2,652 | 2,641 |
(Gain) loss on extinguishment of debt, net | 5 | (30) |
Changes in operating assets and liabilities: | | |
Receivables, net | (1,407) | (816) |
Deferred charges and prepaid expenses | (6,995) | (6,829) |
Other assets | (200) | 82 |
Accounts payable, accrued expenses and other liabilities | (35,828) | (40,199) |
Net cash provided by operating activities | 95,070 | 96,838 |
Investing activities: | | |
Improvements to and investments in real estate assets | (86,696) | (77,725) |
Acquisitions of real estate assets | (2,020) | 0 |
Proceeds from sales of real estate assets | 41,411 | 45,160 |
Purchase of marketable securities | (3,328) | (5,245) |
Proceeds from sale of marketable securities | 4,019 | 5,977 |
Net cash used in investing activities | (46,614) | (31,833) |
Financing activities: | | |
Repayment of secured debt obligations | (7,000) | 0 |
Repayment of borrowings under unsecured revolving credit facility | (7,500) | (65,000) |
Proceeds from borrowings under unsecured revolving credit facility | 646,000 | 50,000 |
Deferred financing and debt extinguishment costs | (404) | (133) |
Partner distributions and repurchases of OP Units | (113,983) | (97,355) |
Net cash provided by (used in) financing activities | 517,113 | (112,488) |
Net change in cash, cash equivalents and restricted cash | 565,569 | (47,483) |
Cash, cash equivalents and restricted cash at beginning of period | 21,507 | 50,639 |
Cash, cash equivalents and restricted cash at end of period | 587,076 | 3,156 |
Reconciliation to consolidated balance sheets: | | |
Cash and cash equivalents | 584,815 | 99 |
Cash, cash equivalents and restricted cash at end of period | 587,076 | 3,156 |
Supplemental disclosure of cash flow information: | | |
Cash paid for interest, net of amount capitalized of $1,063 and $626 | $ 47,023 | $ 51,168 |